Beyond the Bottle: Metabolic Drivers of Alcohol-Associated Liver Disease

Description

This meeting session explores the complex relationship between metabolic dysfunction and alcohol-associated liver disease (ALD), with a focus on emerging clinical insights and risk stratification strategies. The included research abstracts examine the natural history and progression of ALD in the context of metabolic comorbidities, particularly following bariatric surgery. Key objectives include evaluating the risks and potential mitigators of ALD in post-surgical populations and assessing the effectiveness of population-based tools for early identification and risk stratification. The session aims to inform clinical decision-making and guide future research directions in the management of ALD.